Abstract submission opens for Gut Microbiome and Mucosa-Associated Infectious Disease: Mining for Antimicrobials and Postbiotics with Therapeutic Potential
23 May 2022
We are pleased to announce that abstract submission is now open for Gut Microbiome and Mucosa-Associated Infectious Disease: Mining for Antimicrobials and Postbiotics with Therapeutic Potential. The Focused Meeting will take place 27–28 October 2022 at Trinity College Dublin, Ireland.
The gut microbiome plays a crucial role in determining health and wellbeing, influencing the development of the immune system and its interactions with pathogenic microbes. Changes in the microbiome can significantly alter health status and contribute to the development of intestinal infection, with an altered microbiome being found to confer resistance to or promote infection by pathogenic bacteria.
The worldwide occurrence of antimicrobial resistance coupled with the lack of new antimicrobials, is not only jeopardising our ability to treat infectious diseases but also undermining significant breakthrough advances in health and medicine. It is known that antibiotics have a profound impact on the microbiome and can lead to the expansion of pathogenic populations.
The key topics for the meeting include:
- Gut Microbiome in health and disease
- Antimicrobial resistance in bacteria
- New sources of antimicrobials
- Bioactives including effector organisms, probiotics and postbiotics
Further details regarding the programme will be updated in due course via the event page.
Submit your abstract for this Focused Meeting and present your research. The deadline to submit your abstract is 15 August 2022, 23:59 BST.
Further information on registration and invited speakers will be announced in the build up to the meeting on our social media channels and you can follow us on Twitter @MicrobioSoc using the hashtag #MiningMicrobiome22
Image: Science Photo Library/Christoph Burgstedt.
